Frequency and treatment of depressive symptoms in a Parkinson's disease registry

Parkinsonism & Related Disorders
Astrid AlthausRichard Dodel

Abstract

Purpose of this cross-sectional study was to estimate the occurrence of depressive symptoms, as related to other clinical data, in a sample of Parkinson's disease (PD) patients (n=226). Furthermore, we examined the medical care of depressive symptoms in this sample. H&Y stages, cognitive status, sleeping disorders, and dysphagia resulted as significant predictors for depression. Prevalence of depressive symptoms was 35.4%. Only 25.0% of patients suffering from moderate to severe depressive symptoms were prescribed antidepressants. This study supports the view that depression may be underrecognized and undertreated in PD patients. A significant proportion of patients continues to experience depressive symptoms despite antidepressive medication. Recognition and treatment of depression remains a challenge for management of PD. Possible coexisting depressive symptoms should be revealed and assessed by standardized interviews in everyday clinical routine. Large scale randomized controlled trials examining efficacy and safety of antidepressants in PD patients are urgently required.

References

Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·M AsbergG Sedvall
Sep 1, 1992·Journal of the American Geriatrics Society·T N Tombaugh, N J McIntyre
Sep 1, 1989·Archives of Neurology·R G BrownC D Marsden
May 1, 1988·Postgraduate Medical Journal·W R Gibb
Jun 1, 1987·Seminars in Neurology·S Fahn
May 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·R P SnaithC Teale
May 1, 1967·Neurology·M M Hoehn, M D Yahr
May 1, 1997·Archives of Neurology·E TandbergJ L Cummings
May 20, 1999·Pharmacopsychiatry·T J HuberH M Emrich
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Jul 13, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·J R SlaughterM P Martens
Jun 1, 2002·Parkinsonism & Related Disorders·L M ShulmanW J Weiner
Jan 31, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·A F G LeentjensF R J Verhey
Sep 23, 2003·Parkinsonism & Related Disorders·A RojoS Quintana
Dec 4, 2003·Parkinsonism & Related Disorders·T H ChungC E Clarke
Sep 24, 2005·The Journal of Neuropsychiatry and Clinical Neurosciences·Connie VeazeyMark E Kunik
Aug 19, 2006·Arquivos de neuro-psiquiatria·Cláudia Débora SilbermanEliasz Engelhardt

❮ Previous
Next ❯

Citations

Aug 30, 2008·Der Nervenarzt·A StrzelczykW H Oertel
Dec 5, 2008·European Archives of Psychiatry and Clinical Neuroscience·Frank SchneiderRichard Dodel
Jul 19, 2011·Parkinson's Disease·Andreas CharidimouAnette Schrag
Jul 20, 2011·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Annika SpottkeRichard Dodel
Oct 22, 2008·Parkinsonism & Related Disorders·Simon J G Lewis, Roger A Barker
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel Weintraub, David J Burn
Mar 26, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Tanja Schmitz-HübschThomas Klockgether
Oct 15, 2013·Journal of the American Geriatrics Society·Nico J WeerkampBastiaan R Bloem
Aug 2, 2011·Journal of the Neurological Sciences·Take C van der HoekIndira Tendolkar
Aug 28, 2016·Annals of Nuclear Medicine·Young-Do KimYong-Duk Kim
Jun 13, 2012·Journal of Geriatric Psychiatry and Neurology·Sarah YangBenjamin L Walter
Aug 24, 2012·Journal of Geriatric Psychiatry and Neurology·Ana M AbrantesDeborah Riebe
Mar 30, 2011·Journal of Health Psychology·Marília Zampieri, Elisabete Abib Pedroso de Souza
Oct 20, 2018·Biomédica : revista del Instituto Nacional de Salud·Jorge Enrique Machado-AlbaJuan Daniel Castrillón-Spitia
Jun 10, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Daniel Weintraub
Jan 2, 2021·International Journal of Environmental Research and Public Health·Pietro CrispinoMarco Vacante
Aug 28, 2021·International Journal of Environmental Research and Public Health·Elisabeth C DeMarcoLeslie Hinyard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Jennifer S A M ReijndersA F Leentjens
The Journal of Nervous and Mental Disease
S E StarksteinR G Robinson
© 2022 Meta ULC. All rights reserved